Mannatech (MTEX) AI Stock Analysis

• Market Cap: $19.69M
• Dividend Yield: N/A
• Average Volume (3M): 1.96K
• Price to Earnings (P/E): 8.9
• Beta (1Y): 0.47
• Revenue Growth: -9.59%
• EPS Growth: 87.78%
• Country: US
• Employees: 189
• Sector: Consumer Defensive
• Sector Strength: 69
• Industry: Household & Personal Products
• EPS (TTM): -0.81
• Shares Outstanding: 1,900,930
• 10 Day Avg. Volume: 1,699
• 30 Day Avg. Volume: 1,959
• PEG Ratio: 0.85
• Price to Book (P/B): 2.64
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -24.63
• Enterprise Value/Market Cap: 0.80
• Enterprise Value/Revenue: 0.03
• Enterprise Value/Gross Profit: 0.18
• Enterprise Value/Ebitda: 2.41
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 48 Neutral
• Price Target: $10.50 ▲(1.35%Upside)

Mannatech's overall stock score is impacted primarily by poor financial performance and valuation issues, including negative profitability and concerning debt levels. While technical indicators provide some positive short-term signals, they are insufficient to offset the fundamental weaknesses in the company's financial health.

Mannatech Business Overview & Revenue Model

Company Description

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.

How the Company Makes Money

Mannatech generates revenue primarily through the sale of its health and wellness products. The company's business model is based on direct selling, where independent associates and members promote and sell Mannatech's products to consumers. These associates earn commissions and bonuses based on their sales volume, which incentivizes network growth and product distribution. Mannatech's key revenue streams include sales of dietary supplements, skincare products, and weight management solutions. The company also benefits from its Auto Order program, which provides customers with regular shipments of their products, ensuring a consistent revenue stream. Mannatech's international presence and strategic partnerships in various regions contribute to its earnings, enabling it to tap into diverse market demands.

Mannatech Financial Statement Overview

Summary

Mannatech's financial statements reveal significant challenges, including declining revenue, negative profitability, and reduced cash generation capabilities. The company faces operational inefficiencies, reflected in negative EBIT and net income figures in TTM, along with reduced equity levels. While the gross profit margin remains relatively stable, the overall financial health is concerning due to a lack of cash flow and increasing financial leverage. Strategic improvements are necessary to stabilize and enhance financial performance.

Income Statement

Mannatech's income statement indicates a declining trend in revenue and profitability. The TTM (Trailing-Twelve-Months) shows negative net income of -$220,000 and a negative EBIT, reflecting struggles in operational efficiency. Gross profit margin remains stable at around 76.6% in TTM, but the net profit margin has turned negative due to a significant drop in revenue from $159.8 million in 2021 to $115.0 million in TTM. These challenges highlight issues in scaling operations profitably.

Balance Sheet

The balance sheet shows a high level of liabilities compared to equity, with a debt-to-equity ratio of 0.67 in TTM, indicating moderate financial leverage. The equity ratio has decreased to 20.7% from 43.1% in 2020, showing a declining reliance on equity financing. The company maintains a cash position of $9.3 million, but the shrinking stockholders' equity from $24.4 million in 2021 to $7.6 million in TTM suggests potential liquidity concerns if liabilities continue to rise.

Cash Flow

Cash flow analysis reveals declining free cash flow, which turned negative at -$814,000 in TTM, despite positive developments in previous years. The operating cash flow has drastically declined from $10.8 million in 2021 to -$981,000 in TTM, raising concerns about cash generation from core operations. The operating cash flow to net income ratio is negative, indicating inefficiencies in converting profits into cash.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
115.04M	117.87M	131.96M	137.21M	159.76M	151.41M
	Gross Profit
88.10M	91.46M	102.86M	104.15M	125.61M	115.90M
	EBIT
-225.00K	1.43M	-964.00K	-405.00K	9.05M	4.49M
	EBITDA
1.57M	5.55M	702.00K	1.22M	10.77M	6.48M
	Net Income Common Stockholders
-220.00K	2.49M	-2.24M	-4.49M	9.84M	6.26M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
8.85M	11.40M	7.73M	13.78M	24.18M	22.21M
	Total Assets
41.06M	36.06M	41.21M	49.13M	59.63M	65.34M
	Total Debt
5.61M	6.69M	5.73M	412.00K	339.00K	758.00K
	Net Debt
-3.24M	-4.70M	-2.00M	-13.37M	-23.85M	-21.45M
	Total Liabilities
30.61M	27.44M	30.72M	34.95M	35.21M	39.36M
	Stockholders Equity
10.45M	8.61M	10.48M	14.18M	24.41M	25.97M
Cash Flow		Free Cash Flow
-814.00K	1.96M	-3.12M	-3.66M	10.12M	5.08M
	Operating Cash Flow
-981.00K	2.26M	-2.37M	-2.60M	10.77M	6.03M
	Investing Cash Flow
-713.00K	-285.00K	-747.00K	-1.06M	-650.00K	-947.00K
	Financing Cash Flow
2.04M	1.96M	-1.90M	-4.33M	-9.29M	-9.92M

Mannatech Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 10.36
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTEX, the sentiment is Positive. The current price of 10.36 is above the 20-day moving average (MA) of 10.26, above the 50-day MA of 9.82, and above the 200-day MA of 9.72, indicating a bullish trend. The MACD of -0.06 indicates Negative momentum. The RSI at 52.18 is Neutral, neither overbought nor oversold. The STOCH value of 49.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MTEX.

Mannatech Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
UG	71 Outperform	$37.44M	12.97	26.24%	8.53%	11.91%	25.93%
TKLF	70 Outperform	$16.55M	2.14	20.48%	―	―	―
Sector *	65 Neutral	$8.94B	14.98	4.76%	203.76%	3.54%	-2.49%
TANH	56 Neutral	$2.93M	1.82	-1.68%	―	6.27%	-34.07%
SKIN	56 Neutral	$207.92M	―	-70.44%	―	-17.97%	49.13%
MTEX	48 Neutral	$19.69M	8.92	-2.44%	―	-9.59%	87.78%
GROV	46 Neutral	$53.14M	―	-180.03%	―	-19.83%	22.76%

Mannatech Corporate Events

Mannatech Approves Proposals at Annual Shareholders’ Meeting

On June 3, 2025, Mannatech, Incorporated held its annual shareholders’ meeting where all proposals were approved by the shareholders. The meeting saw the election of J. Stanley Fredrick and Tyler J. Rameson as Class II directors, the ratification of BDO USA, P.C. as the independent public accounting firm, and advisory approvals on executive compensation and its voting frequency. Approximately 77.8% of the total shares were represented at the meeting, indicating strong shareholder engagement.